HLS- Cyclic CAR peptide: a targeted therapy for pulmonary hypertension
IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
-
Activity
R42
-
Administering IC
HL
-
Application Type
4
-
Direct Cost Amount
-
Indirect Cost Amount
-
Total Cost
1255432
-
Sub Project Total Cost
-
ARRA Funded
False
-
CFDA Code
838
-
Ed Inst. Type
-
Funding ICs
NHLBI:1255432\
-
Funding Mechanism
SBIR-STTR RPGs
-
Study Section
ZRG1
-
Study Section Name
Special Emphasis Panel